This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2008-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Natick, MA (US) (2012)
- Waltham, MA (US) (2008 - 2014)
Company Filing History:
Years Active: 2008-2014
Title: The Innovative Contributions of Dingwei Yu
Introduction
Dingwei Yu is a prominent inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 5 patents to his name, his work has the potential to impact cancer treatment significantly.
Latest Patents
Dingwei Yu's latest patents include the invention of Pyrazolylaminopyridine derivatives, which are useful as kinase inhibitors. This invention relates to novel compounds having the formula (I) and their pharmaceutical compositions. These compounds are designed to provide effective treatment options for cancer, showcasing the innovative nature of his work.
Career Highlights
Dingwei Yu is currently associated with AstraZeneca, a leading global biopharmaceutical company. His role at AstraZeneca allows him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in creating novel compounds has positioned him as a valuable asset in the fight against cancer.
Collaborations
Dingwei Yu collaborates with talented professionals in his field, including Michelle Lamb and Tao Wang. These collaborations enhance the research and development process, leading to innovative solutions in cancer treatment.
Conclusion
Dingwei Yu's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his commitment to advancing cancer treatment. His work at AstraZeneca and collaborations with other professionals further emphasize the importance of teamwork in achieving significant breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile